Bank of New York Mellon Corp - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 212 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$6,737,749
-29.7%
287,569
-0.8%
0.00%
-50.0%
Q1 2024$9,577,876
-19.7%
289,888
-33.9%
0.00%0.0%
Q4 2023$11,933,371
+0.5%
438,405
-11.2%
0.00%
-33.3%
Q3 2023$11,878,664
-22.8%
493,916
+2.5%
0.00%0.0%
Q2 2023$15,385,664
+5.5%
481,856
+1.1%
0.00%0.0%
Q1 2023$14,587,159
-24.3%
476,393
-3.3%
0.00%
-25.0%
Q4 2022$19,269,926
-19.4%
492,711
-1.9%
0.00%
-33.3%
Q3 2022$23,915,000
+30.5%
502,008
+6.1%
0.01%
+50.0%
Q2 2022$18,319,000
+29.2%
473,244
+91.3%
0.00%
+33.3%
Q1 2022$14,175,000
-28.7%
247,376
-0.9%
0.00%
-25.0%
Q4 2021$19,890,000
-5.3%
249,608
+3.4%
0.00%0.0%
Q3 2021$21,011,000
-24.1%
241,479
+12.2%
0.00%
-20.0%
Q2 2021$27,696,000
+101.8%
215,175
+25.5%
0.01%
+66.7%
Q1 2021$13,725,000
-16.8%
171,468
-15.1%
0.00%
-25.0%
Q4 2020$16,487,000
+360.1%
201,964
+38.7%
0.00%
+300.0%
Q3 2020$3,583,000
+54.8%
145,566
+76.1%
0.00%0.0%
Q2 2020$2,314,000
+474.2%
82,644
+268.6%
0.00%
Q1 2020$403,00022,4210.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$56,443,76354.70%
HSG Holding Ltd 796,089$19,145,9402.05%
Redmile Group, LLC 1,469,725$35,346,8861.68%
ARK Investment Management 8,783,891$211,252,5901.62%
Casdin Capital, LLC 570,000$13,708,5001.52%
Deep Track Capital, LP 1,015,641$24,426,1660.94%
Yiheng Capital Management, L.P. 560,500$13,480,0250.69%
Temasek Holdings (Private) Ltd 4,317,789$103,842,8250.62%
FARALLON CAPITAL MANAGEMENT LLC 4,481,839$107,788,2280.50%
Alphabet Inc. 321,604$7,734,5760.50%
View complete list of BEAM THERAPEUTICS INC shareholders